Sundrug Co Ltd
TSE:9989
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 440
4 890
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sundrug Co Ltd
Total Liabilities & Equity
Sundrug Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Sundrug Co Ltd
TSE:9989
|
Total Liabilities & Equity
ÂĄ416.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
||
Tsuruha Holdings Inc
TSE:3391
|
Total Liabilities & Equity
ÂĄ556.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
||
Welcia Holdings Co Ltd
TSE:3141
|
Total Liabilities & Equity
ÂĄ621B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Total Liabilities & Equity
ÂĄ446.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Total Liabilities & Equity
ÂĄ716.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Total Liabilities & Equity
ÂĄ485B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
Sundrug Co Ltd
Glance View
Sundrug Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Fuchu-Shi, Tokyo-To and currently employs 5,634 full-time employees. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.
See Also
What is Sundrug Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
416.2B
JPY
Based on the financial report for Jun 30, 2024, Sundrug Co Ltd's Total Liabilities & Equity amounts to 416.2B JPY.
What is Sundrug Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
9%
Over the last year, the Total Liabilities & Equity growth was 18%. The average annual Total Liabilities & Equity growth rates for Sundrug Co Ltd have been 11% over the past three years , 9% over the past five years , and 9% over the past ten years .